These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8561936)

  • 21. Is there a reasonable differential indication for different hydrocephalus shunt systems?
    Trost HA
    Childs Nerv Syst; 1995 Apr; 11(4):189-92. PubMed ID: 7621478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the risk of shunt failure or infection related to cerebrospinal fluid cell count, protein level, and glucose levels in low-birth-weight premature infants with posthemorrhagic hydrocephalus.
    Fulkerson DH; Vachhrajani S; Bohnstedt BN; Patel NB; Patel AJ; Fox BD; Jea A; Boaz JC
    J Neurosurg Pediatr; 2011 Feb; 7(2):147-51. PubMed ID: 21284459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CSF shunt removal in children with hydrocephalus.
    Iannelli A; Rea G; Di Rocco C
    Acta Neurochir (Wien); 2005 May; 147(5):503-7; discussion 507. PubMed ID: 15838593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-pressure hydrocephalic state and viscoelastic alterations in the brain.
    Pang D; Altschuler E
    Neurosurgery; 1994 Oct; 35(4):643-55; discussion 655-6. PubMed ID: 7808607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in cerebrospinal fluid hydrodynamics following endoscopic third ventriculostomy for shunt-dependent noncommunicating hydrocephalus.
    Nishiyama K; Mori H; Tanaka R
    J Neurosurg; 2003 May; 98(5):1027-31. PubMed ID: 12744362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Explanted shunt valves: factors contributing to their failure.
    Brydon HL; Bayston R; Hayward RD; Harkness WF
    Eur J Pediatr Surg; 1994 Dec; 4 Suppl 1():37-8. PubMed ID: 7766553
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group.
    Pollack IF; Albright AL; Adelson PD
    Neurosurgery; 1999 Dec; 45(6):1399-408; discussion 1408-11. PubMed ID: 10598708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hydrocephalus with Cordis-Hakim valve (author's transl)].
    Schubert W; Prater C; Roesner D
    Z Kinderchir; 1981 May; 33(1):18-24. PubMed ID: 7257613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiloculated hydrocephalus related to cerebrospinal fluid shunt infection.
    Jamjoom AB; Mohammed AA; al-Boukai A; Jamjoom ZA; Rahman N; Jamjoom HT
    Acta Neurochir (Wien); 1996; 138(6):714-9. PubMed ID: 8836287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The predictive value of cerebrospinal fluid dynamic tests in patients with th idiopathic adult hydrocephalus syndrome.
    Malm J; Kristensen B; Karlsson T; Fagerlund M; Elfverson J; Ekstedt J
    Arch Neurol; 1995 Aug; 52(8):783-9. PubMed ID: 7639630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transport and production of cerebrospinal fluid (CSF) change in aging humans under normal and diseased conditions.
    Kleine TO; Hackler R; Lütcke A; Dauch W; Zöfel P
    Z Gerontol; 1993; 26(4):251-5. PubMed ID: 8212795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Change in ventricular size and effect of ventricular catheter placement in pediatric patients with shunted hydrocephalus.
    Tuli S; O'Hayon B; Drake J; Clarke M; Kestle J
    Neurosurgery; 1999 Dec; 45(6):1329-33; discussion 1333-5. PubMed ID: 10598700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow characteristics of cerebrospinal fluid shunt tubing.
    Cheatle JT; Bowder AN; Agrawal SK; Sather MD; Hellbusch LC
    J Neurosurg Pediatr; 2012 Feb; 9(2):191-7. PubMed ID: 22295926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption.
    Brydon HL; Keir G; Thompson EJ; Bayston R; Hayward R; Harkness W
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):643-7. PubMed ID: 9598681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An adjustable CSF shunt: advices for clinical use.
    Lundkvist B; Eklund A; Koskinen LO; Malm J
    Acta Neurol Scand; 2003 Jul; 108(1):38-42. PubMed ID: 12807391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of using siphon-reducing devices.
    Kremer P; Aschoff A; Kunze S
    Childs Nerv Syst; 1994 May; 10(4):231-5. PubMed ID: 7923232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventricular shunt tap as a predictor of proximal shunt malfunction in children: a prospective study.
    Rocque BG; Lapsiwala S; Iskandar BJ
    J Neurosurg Pediatr; 2008 Jun; 1(6):439-43. PubMed ID: 18518693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PROSAIKA: a prospective multicenter registry with the first programmable gravitational device for hydrocephalus shunting.
    Kehler U; Kiefer M; Eymann R; Wagner W; Tschan CA; Langer N; Rohde V; Ludwig HC; Gliemroth J; Meier U; Lemcke J; Thomale UW; Fritsch M; Krauss JK; Mirzayan MJ; Schuhmann M; Huthmann A
    Clin Neurol Neurosurg; 2015 Oct; 137():132-6. PubMed ID: 26196478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Pressure Shunt for Simultaneous Diversion of Ventricular Fluid and Extracerebral Fluid.
    Craig D; Winston KR; Folzenlogen Z; Beauchamp KA
    Pediatr Neurosurg; 2018; 53(1):13-17. PubMed ID: 28934739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF outflow resistance as predictor of shunt function. A long-term study.
    Malm J; Lundkvist B; Eklund A; Koskinen LO; Kristensen B
    Acta Neurol Scand; 2004 Sep; 110(3):154-60. PubMed ID: 15285771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.